Search - tctmd.com

Displaying 881 - 900 of 1234

Sort: Relevancy | Date

Presentation TCT 2017

Case Presentation: Severe Aortic Stenosis in a 65-Year-Old Man With COPD

Presenter: Habib Gamra, Mohamed Ahmed Sobhy, Yasser Sadek

October 29, 2017

Presentation TCT 2017

A Recorded Case of Balloon Valvuloplasty for Rheumatic Mitral Stenosis (With Integrated Discussion)

Presenter: Habib Gamra, Mohamed Ahmed Sobhy, Riaz S Dawood

October 29, 2017

Presentation TCT 2017

Epidemiology of Valvular Heart Disease in the Middle East and Africa

Presenter: Habib Gamra, Mohamed Ahmed Sobhy, Shaheen Pandie

October 29, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Conference News TCT 2016

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

L.A. McKeown

November 07, 2016

News Industry News TCT 2016

Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

November 02, 2016

News Industry News TCT 2016

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

November 02, 2016

News Conference News TCT 2016

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Yael L. Maxwell

November 02, 2016

Presentation TCT 2016

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

Presenter: Eustaquio Maria Onorato, Richard Smalling, Robert J. Sommer

November 01, 2016

Presentation TCT 2016

The REDUCE Trial: Will It Be Positive and What Will We Learn?

Presenter: Eustaquio Maria Onorato, Richard Smalling, John F. Rhodes

November 01, 2016

Presentation TCT 2016

What Should Be the Next Series of Clinical Trials in PFO Closure?

Presenter: Eustaquio Maria Onorato, Richard Smalling, John D. Carroll

November 01, 2016

Presentation TCT 2016

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

Presenter: Eustaquio Maria Onorato, Richard Smalling, David E. Thaler

November 01, 2016

Presentation TCT 2016

Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies

Presenter: Eustaquio Maria Onorato, Richard Smalling

November 01, 2016

Presentation TCT 2016

Building a Successful PFO Closure Program

Presenter: John D. Carroll, Christian Spies

November 01, 2016

Presentation TCT 2016

Available Devices/Techniques for Closure of PFO

Presenter: John D. Carroll, Christian Spies, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

The RoPE Score: How to select pathologic PFO?

Presenter: John D. Carroll, Christian Spies, David E. Thaler

November 01, 2016

Presentation TCT 2016

What Do the Randomized Clinical Trials Tell Us and How Did the FDA Respond?

Presenter: John D. Carroll, Christian Spies

November 01, 2016

Presentation TCT 2016

Impact of Percutaneous Mitral Valve Repair and Replacement on RHD Patient Outcomes

Presenter: Habib Gamra, Ahmed Suliman, Hugh J. Linnehan

November 01, 2016

Presentation TCT 2016

Long-term Outcomes of Coarctation Stenting

Presenter: John D. Carroll, Thomas J Forbes

November 01, 2016

Presentation TCT 2016

Delivery System and Therapeutic Challenges with RHD in Africa

Presenter: Habib Gamra, Ahmed Suliman, Mohamed Ahmed Sobhy

November 01, 2016

Advertisement

Case Presentation: Severe Aortic Stenosis in a 65-Year-Old Man With COPD

A Recorded Case of Balloon Valvuloplasty for Rheumatic Mitral Stenosis (With Integrated Discussion)

Epidemiology of Valvular Heart Disease in the Middle East and Africa

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

The REDUCE Trial: Will It Be Positive and What Will We Learn?

What Should Be the Next Series of Clinical Trials in PFO Closure?

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies

Building a Successful PFO Closure Program

Available Devices/Techniques for Closure of PFO

The RoPE Score: How to select pathologic PFO?

What Do the Randomized Clinical Trials Tell Us and How Did the FDA Respond?

Impact of Percutaneous Mitral Valve Repair and Replacement on RHD Patient Outcomes

Long-term Outcomes of Coarctation Stenting

Delivery System and Therapeutic Challenges with RHD in Africa

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content